Oncotype DX GPS testing
Ended Awarded Last action
- Contract number
- 36C26125N0276
- Awardee
-
Mdxhealth, Inc. UEI LQGYDJJ9K8Q6
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $269,429
Award facts
- Contract value 22% obligated
-
- $269,429.31 Current, with exercised options
- $1,222,115.31 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Mather, CA, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $89,777 | |
| Original award | $179,652 |
About this award
Mdxhealth, Inc. has been awarded a $1.22M delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) for Oncotype DX GPS (Genomic Prostate Score) testing services. This firm fixed-price contract, effective through January 31, 2030, represents a call order against Mdxhealth's existing Blanket Purchase Agreement under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The work will be performed in Mather, California, and the award carries no small business set-aside designation, indicating competition as a standard commercial vendor.
Mdxhealth specializes in molecular diagnostic testing for cancer screening, with a primary focus on prostate cancer diagnostics for the VA system. The Oncotype DX GPS test provides genomic analysis to support personalized treatment decision-making for veterans, enabling clinicians to assess prostate cancer risk and inform clinical management strategies. This delivery order aligns with Mdxhealth's existing portfolio of VA contracts, which includes multiple BPAs across different VISNs totaling several million dollars for similar advanced diagnostic laboratory services. The contract structure allows VISN 21 to efficiently access Mdxhealth's specialized capabilities as needed through January 2030.
Quick answers
Who was awarded contract 36C26125N0276?
36C26125N0276 was awarded to Mdxhealth, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on February 1, 2025.
How much is contract 36C26125N0276 worth?
The government has obligated $269,429 on 36C26125N0276. Its potential value, with all options, is $1,222,115.
Is contract 36C26125N0276 an order under another contract?
Yes. 36C26125N0276 is a delivery order under V797D70066, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C26125N0276 competed?
The extent of competition for 36C26125N0276 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award